Evidence map›Paper›PMID 41254407›Full record

ArticleInternational journal of colorectal disease2025

Safety and feasibility of novel single-port robotic systems in colorectal cancer surgery: a comparative study with the da Vinci Xi system.

Ang Shi, Jingwei Zheng, Dongze Wu, Xinxin Yang, Zhixuan Jiang, Xiaodong Chen, Weiteng Zhang, Weijian Sun, Ji Lin, Jun Cheng and 2 more

Abstract readComparative Study
In one paragraph

Article in International journal of colorectal disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ang Shi *Department of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China.
Jingwei Zheng *Department of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China.
Dongze WuDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China.
Xinxin YangDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China.
Zhixuan JiangDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China.
Xiaodong ChenDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China.
Weiteng ZhangDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China.
Weijian SunDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China.
Ji LinDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China.
Jun ChengDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China. 1043475708@qq.com.
Qiantong DongDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China. dongqt2021@wmu.edu.cn.
Xian ShenDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China. shenxian1120@126.com.

Funding

National Key Research and Development Program of China Grant number:2023YFC2413402Science and Technology Program of Zhejiang Province 2024ZY01003
6 · The paper itself

Abstract

purposeTo compare perioperative outcomes and safety between the novel single-port robotic systems (SPRS) and the da Vinci Xi robotic system (DVRS) in radical colorectal cancer resection.

methodsIn this retrospective cohort study, 59 patients who underwent curative colorectal resection were assigned to either the SPRS group (n = 21) or the DVRS group (n = 38). Intraoperative metrics, postoperative recovery parameters, and complications were compared between groups.

resultsAll procedures were successfully completed without open conversion and the number of lymph nodes harvested was comparable. The SPRS group demonstrated significantly longer operative times (298.86 ± 76.08 min vs. 227.84 ± 70.20 min; p < 0.001). No significant differences were observed in estimated blood loss, time of gastrointestinal recovery(first flatus), time of dietary resumption (liquid/soft diet), or 30-day readmission rates (p > 0.05). The DVRS group exhibited prolonged median postoperative hospitalization (10.00 days [IQR 8.00-11.75] vs. 8.00 days [IQR 7.00-9.00]; p < 0.05). Patients in the SPRS group reported significantly higher satisfaction scores regarding the cosmetic appearance of postoperative scars compared to those in the DVRS group(7.71 ± 1.01 vs. 6.66 ± 0.91; p < 0.001). Complication rates showed no statistical difference (p > 0.05). All complications were Clavien-Dindo grade I-II managed conservatively, except one SPRS case requiring endoscopic intervention for grade IIIa gastrointestinal hemorrhage.

conclusionsThe novel single-port robotic systems are safe and feasible for radical colorectal cancer surgery. They achieve short-term outcomes comparable to the da Vinci Xi system, with the advantages of a shorter hospitalization and better cosmetic outcomes but at the expense of a longer operative time.

Indexed as

Colorectal NeoplasmsRobotic Surgical ProceduresAgedFeasibility StudiesFemaleHumansMaleMiddle AgedOperative TimePostoperative ComplicationsRetrospective StudiesTreatment OutcomeColorectal cancerDa Vinci robotic systemSingle-port robotic surgerySurgical outcome

Identifiers

PMID41254407
PMCPMC12627135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.